BioCentury | Oct 22, 2007
Strategy

One deal at a time

Orexo AB is acquiring Biolipox AB to add critical mass and put the company in a better position for future M&A. Orexo hopes a future purchase of a sales and marketing company will enable it...
BioCentury | May 29, 2006
Strategy

Going for aggregation

...both boards - something that facilitated the deal, she added. Other major CareX investors were Credit Lyonnais...
BioCentury | May 15, 2006
Finance

Ebb & Flow

...has raised $40.7 million in two venture rounds. Investors include Innoven Partners; Biotech Fund Flanders; Credit Lyonnais...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Partners Biolipox Sweden $41.0 Scandinavian Life Science Venture; HealthCap; Apax Partners; Sofinnova Partners; Auriga Partners; Credit Lyonnais...
BioCentury | Jan 24, 2005
Emerging Company Profile

Corporate Profile

...Employees: 20 Funds raised: E10 million ($11.9 million) Investors: Bioam; Axa Private Equity; Auriga Ventures; Credit Lyonnais...
BioCentury | Jan 17, 2005
Finance

Ebb & Flow

JPMorgan's 23rd Annual Healthcare Conference last week could be summed up in two words: rational optimism. Rational because companies and investors both agree that valuations aren't going to spiral upward out of control anytime soon....
BioCentury | May 24, 2004
Finance

Top European B rounds

...Ltd.; ABN AMRO; 3i; Green Highlander CareX $31.2 3/8/04 Metabolic; functional genomics France Index Ventures; Credit Lyonnais...
...Fund; other investors Biolipox $22.2 1/15/03 Inflammation; neurology; pulmonary Sweden Apax Partners; HealthCap; Sofinnova Partners; Credit Lyonnais...
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...Index Ventures; Heidelberg Innovation; Schroder Ventures; Sofinnova Partners; Stelios Papadopoulos CareX France $31.2 Index Ventures; Credit Lyonnais...
BioCentury | May 3, 2004
Finance

Ebb & Flow

...decline. The falloff continued through the month, and PRM last Wednesday notified the market that Credit Lyonnais...
BioCentury | Mar 15, 2004
Finance

Ebb & Flow

...LXR alpha modulator for dyslipidemia. The round was led by Index Partners. Other investors included Credit Lyonnais...
Items per page:
1 - 10 of 23
BioCentury | Oct 22, 2007
Strategy

One deal at a time

Orexo AB is acquiring Biolipox AB to add critical mass and put the company in a better position for future M&A. Orexo hopes a future purchase of a sales and marketing company will enable it...
BioCentury | May 29, 2006
Strategy

Going for aggregation

...both boards - something that facilitated the deal, she added. Other major CareX investors were Credit Lyonnais...
BioCentury | May 15, 2006
Finance

Ebb & Flow

...has raised $40.7 million in two venture rounds. Investors include Innoven Partners; Biotech Fund Flanders; Credit Lyonnais...
BioCentury | May 23, 2005
Finance

U.S. investment in Europe

...Partners Biolipox Sweden $41.0 Scandinavian Life Science Venture; HealthCap; Apax Partners; Sofinnova Partners; Auriga Partners; Credit Lyonnais...
BioCentury | Jan 24, 2005
Emerging Company Profile

Corporate Profile

...Employees: 20 Funds raised: E10 million ($11.9 million) Investors: Bioam; Axa Private Equity; Auriga Ventures; Credit Lyonnais...
BioCentury | Jan 17, 2005
Finance

Ebb & Flow

JPMorgan's 23rd Annual Healthcare Conference last week could be summed up in two words: rational optimism. Rational because companies and investors both agree that valuations aren't going to spiral upward out of control anytime soon....
BioCentury | May 24, 2004
Finance

Top European B rounds

...Ltd.; ABN AMRO; 3i; Green Highlander CareX $31.2 3/8/04 Metabolic; functional genomics France Index Ventures; Credit Lyonnais...
...Fund; other investors Biolipox $22.2 1/15/03 Inflammation; neurology; pulmonary Sweden Apax Partners; HealthCap; Sofinnova Partners; Credit Lyonnais...
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...Index Ventures; Heidelberg Innovation; Schroder Ventures; Sofinnova Partners; Stelios Papadopoulos CareX France $31.2 Index Ventures; Credit Lyonnais...
BioCentury | May 3, 2004
Finance

Ebb & Flow

...decline. The falloff continued through the month, and PRM last Wednesday notified the market that Credit Lyonnais...
BioCentury | Mar 15, 2004
Finance

Ebb & Flow

...LXR alpha modulator for dyslipidemia. The round was led by Index Partners. Other investors included Credit Lyonnais...
Items per page:
1 - 10 of 23